ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Thirtyfivebio Limited

Thirtyfivebio Limited is an active company incorporated on 26 January 2021 with the registered office located in Abingdon, Oxfordshire. Thirtyfivebio Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13157735
Private limited company
Age
4 years
Incorporated 26 January 2021
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 25 January 2025 (9 months ago)
Next confirmation dated 25 January 2026
Due by 8 February 2026 (2 months remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
99 Park Drive
Milton
Abingdon
OX14 4RY
England
Address changed on 4 Aug 2022 (3 years ago)
Previous address was 57 Woodstock Road Oxford OX2 6HJ England
Telephone
01235 644980
Email
Unreported
Website
Unreported
People
Officers
6
Shareholders
33
Controllers (PSC)
1
Director • American • Lives in United States • Born in Feb 1956
Director • American,australian • Lives in England • Born in Sep 1973
Director • American • Lives in United States • Born in Mar 1963
Director • Australian • Lives in England • Born in Jun 1967
Director • British • Lives in England • Born in Oct 1974
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Orbit Discovery Group Ltd
Dr Thomas David McCarthy is a mutual person.
Active
Orbit Discovery Ltd
Dr Thomas David McCarthy is a mutual person.
Active
Tfbio Limited
Dr Thomas David McCarthy is a mutual person.
Active
PTT Bio Limited
Dr Thomas David McCarthy is a mutual person.
Active
M:M Bio Global Incubator Limited
Dr Thomas David McCarthy is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£353K
Decreased by £1.6M (-82%)
Turnover
Unreported
Same as previous period
Employees
8
Increased by 2 (+33%)
Total Assets
£985K
Decreased by £1.82M (-65%)
Total Liabilities
-£997K
Increased by £588K (+144%)
Net Assets
-£12K
Decreased by £2.41M (-101%)
Debt Ratio (%)
101%
Increased by 86.65% (+595%)
Latest Activity
Full Accounts Submitted
29 Days Ago on 16 Oct 2025
Own Shares Purchased
3 Months Ago on 30 Jul 2025
Shares Cancelled
3 Months Ago on 30 Jul 2025
Dr Donmienne Doen Mun Leung Appointed
8 Months Ago on 11 Mar 2025
Confirmation Submitted
9 Months Ago on 30 Jan 2025
Full Accounts Submitted
1 Year 1 Month Ago on 24 Sep 2024
Confirmation Submitted
1 Year 9 Months Ago on 7 Feb 2024
Small Accounts Submitted
2 Years 5 Months Ago on 24 May 2023
Shares Cancelled
2 Years 8 Months Ago on 20 Feb 2023
Own Shares Purchased
2 Years 8 Months Ago on 20 Feb 2023
Get Credit Report
Discover Thirtyfivebio Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 16 Oct 2025
Information not on the register a notice of cancellation of shares was removed on 03/10/2025 as it is no longer considered to form part of the register.
Submitted on 3 Oct 2025
Information not on the register a filing of return of purchase of own shares was removed on 03/10/2025 as it is no longer considered to form part of the register.
Submitted on 3 Oct 2025
Purchase of own shares.
Submitted on 30 Jul 2025
Cancellation of shares. Statement of capital on 16 July 2025
Submitted on 30 Jul 2025
Resolutions
Submitted on 29 Jul 2025
Change of share class name or designation
Submitted on 28 Jul 2025
Particulars of variation of rights attached to shares
Submitted on 25 Jul 2025
Statement of capital following an allotment of shares on 27 February 2025
Submitted on 17 Mar 2025
Resolutions
Submitted on 14 Mar 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year